Meeder Asset Management Inc Neogenomics Inc Transaction History

Meeder Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $180 - $296	23 Added 2.99%	791 $7,000
Q2 2022 Aug 08, 2022	BUY	$7.06 - $13.97 $2,463 - $4,875	349 Added 83.29%	768 $6,000
Q1 2022 May 10, 2022	BUY	$12.15 - $35.28 $3,365 - $9,772	277 Added 195.07%	419 $5,000
Q4 2021 Feb 11, 2022	BUY	$30.49 - $48.49 $1,920 - $3,054	63 Added 79.75%	142 $5,000
Q3 2021 Nov 08, 2021	BUY	$41.66 - $52.52 $1,666 - $2,100	40 Added 102.56%	79 $4,000
Q1 2021 Apr 28, 2021	BUY	$41.56 - $59.88 $124 - $179	3 Added 8.33%	39 $2,000
Q4 2020 Feb 09, 2021	BUY	$36.08 - $56.47 $721 - $1,129	20 Added 125.0%	36 $2,000
Q2 2020 Aug 11, 2020	BUY	$24.21 - $31.02 $387 - $496	16 New	16 $0
Q1 2019 Apr 16, 2019	SELL	$12.14 - $20.46 $5,754 - $9,698	-474 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$11.24 - $18.5 $1,135 - $1,868	-101 Reduced 17.57%	474 $6,000
Q3 2018 Nov 02, 2018	BUY	$12.5 - $15.38 $7,187 - $8,843	575 New	575 $0

282

124M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.21B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.